Skip to main content

3 Result(s)

within Delphine C. Malherbe Remove this filter Biomedicine Remove this filter Virology Remove this filter

and

  1. Article

    Open Access

    Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection

    We introduce a new vaccine platform against Marburg virus (MARV) combining the advantages of the immunogenicity of a highly attenuated vaccine vector (Modified Vaccinia Ankara, MVA) with the authentic conforma...

    Delphine C. Malherbe, Arban Domi, Mary J. Hauser, Michelle Meyer… in npj Vaccines (2020)

    Download PDF (1249 KB) View Article

  2. Article

    Open Access

    A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19

    The development of effective countermeasures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the COVID-19 pandemic, is a priority. We designed and produced ConVa...

    Delphine C. Malherbe, Drishya Kurup, Christoph Wirblich, Adam J. Ronk… in npj Vaccines (2021)

    Download PDF (3982 KB) View Article

  3. Article

    Open Access

    A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection

    A new vectored vaccine MVA-VLP-SUDV was generated against Sudan ebolavirus (SUDV) combining the advantages of the immunogenicity of a live attenuated vaccine vector (Modified Vaccinia Ankara, MVA) with the aut...

    Delphine C. Malherbe, Arban Domi, Mary J. Hauser, Caroline Atyeo… in npj Vaccines (2022)

    Download PDF (1958 KB) View Article